End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,070 KRW | -2.05% | -3.67% | +4.23% |
Business Summary
Number of employees: 66
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Enzymes and Material Business
94.4
%
| 27,802 | 100.0 % | 25,500 | 94.4 % | -8.28% |
New Drug Development
5.6
%
| 0 | 0.0 % | 1,508 | 5.6 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
68.0
%
| 17,044 | 61.3 % | 18,358 | 68.0 % | +7.71% |
Others
11.9
%
| 2,932 | 10.5 % | 3,216 | 11.9 % | +9.69% |
Netherlands
9.7
%
| 4,606 | 16.6 % | 2,626 | 9.7 % | -42.99% |
England
7.2
%
| 1,443 | 5.2 % | 1,957 | 7.2 % | +35.60% |
United States
3.2
%
| 1,777 | 6.4 % | 852 | 3.2 % | -52.06% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eui-Joong Kim
CEO | Chief Executive Officer | 51 | - |
Jae-Gu Pan
FOU | Founder | 66 | 00-03-28 |
Jong-Min Na
AUD | Comptroller/Controller/Auditor | 50 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jae-Gu Pan
FOU | Founder | 66 | 00-03-28 |
Eui-Joong Kim
CEO | Chief Executive Officer | 51 | - |
Jung-Hyeon Kim
BRD | Director/Board Member | 60 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 580,908 | 0 | 0 | 66.29 % |
Stock B | 1 | 22,758,430 | 15,087,168 ( 66.29 %) | 0 |
Company contact information
GenoFocus, Inc.
Unit 201, Migun Techno World II 65 Techno 1-ro
34014, Daejeon
+
http://www.genofocus.comSales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+4.23% | 68.77M | |
+5.33% | 105B | |
-3.11% | 64.71B | |
+74.29% | 49.72B | |
+15.53% | 38.6B | |
+5.11% | 32.54B | |
+10.79% | 19.94B | |
+13.07% | 16.92B | |
+18.38% | 15.2B | |
+4.83% | 14.39B |
- Stock Market
- Equities
- A187420 Stock
- Company GenoFocus, Inc.